Evidence map›Paper›PMID 37071294›Full record

SynthesisApoptosis : an international journal on programmed cell death2023

Bibliometric analysis and mini-review of global research on pyroptosis in the field of cancer.

Wenwen Wang, Wenhuizi Sun, Han Xu, Yao Liu, Chenlu Wei, Siqiao Wang, Shuyuan Xian, Penghui Yan, Jiajun Zhang, Hongjun Guo and 7 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Apoptosis : an international journal on programmed cell death, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Death never dies: increasing impact of programmed cell death.Apoptosis : an international journal on programmed cell death · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. A cellular danse macabre: the choreography of programmed cell death.Apoptosis : an international journal on programmed cell death · 2025
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Wenwen Wang *Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Wenhuizi Sun *Department of Obstetrics and Gynecology, Tongji Hospital, School of Medicine, Tongji University, 200065, Shanghai, China.
Han Xu *Department of Obstetrics and Gynecology, East Hospital, School of Medicine, Tongji University, 200120, Shanghai, China.
Yao Liu *Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China. 15903650068@163.com.
Chenlu WeiDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Siqiao WangTongji University School of Medicine, 200092, Shanghai, China.
Shuyuan XianTongji University School of Medicine, 200092, Shanghai, China.
Penghui YanDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Jiajun ZhangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Hongjun GuoDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Hengwei QinShanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Jie LianDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Xiangyu HanDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Jiaqi ZhangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China.
Ruixia GuoDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China. grxcdxzzu@163.com.
Jie ZhangTongji University School of Medicine, 200092, Shanghai, China. jiezhang@tongji.edu.cn.
Zongqiang HuangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, 450052, Zhengzhou, China. gzhuangzq@163.com.
First Affiliated Hospital of Zhengzhou University · CNTongji University · CNShanghai Jiao Tong University · CNHenan Provincial Center for Disease Control and Prevention · CNShanghai East Hospital · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyroptosis is one of the mechanisms of programmed cell death (PCD) activated by inflammasomes and involved by the caspase family and the gasdermin family. During the oncogenesis and progression of tumors, pyroptosis is crucial, and complex withal. Currently, pyroptosis is the focus topic in the research field of oncology, but there is no single bibliometric analysis systematically studying 'pyroptosis and cancer'. Our study aimed to visualize the research status of pyroptosis in oncology and excavate the hotspots and prospects in this field. Furthermore, in consideration of the professional direction of researchers, we particularly emphasized articles on pyroptosis in gynecology and formed a mini systematic review. This bibliometric work integrated and analyzed all articles from ISI Web of Science: Science Citation Index Expanded (SCI-Expanded) (dated April 25th, 2022), based on quantitative and visual mapping approaches. Systematically reviewing articles on pyroptosis in gynecology helped us complement our analysis of research advancements in this field. Including 634 articles, our study found that the number of articles on pyroptosis in cancer increased exponentially in recent years. These publications came from 45 countries and regions headed by China and the US mainly aiming at the mechanism of pyroptosis in cell biology and biochemistry molecular biology, as well as the role of pyroptosis in the development and therapeutic application of various cancers. The top 20 most cited studies on this topic mostly came from the US, followed by China and England, and half of the articles cited more than 100 times in total were published in Nature. Moreover, as for gynecologic cancer, in vitro and bioinformatics analysis were the main methodology conducting to explore roles of pyroptosis-related genes (PRGs) and formation of inflammasomes in cancer progression and prognosis. Pyroptosis has evolved into a burgeoning research field in oncology. The cellular and molecular pathway mechanism of pyroptosis, as well as the effect of pyroptosis in oncogenesis, progression, and treatment have been the hot topic of the current study and provided us the future direction as the potential opportunities and challenges. We advocate more active cooperation to improve therapeutic strategies for cancer.

Indexed as

NeoplasmsPyroptosisApoptosisBibliometricsCarcinogenesisCell Transformation, NeoplasticFemaleHumansInflammasomesInflammasomesGlobal researchGynecologyInflammasomesPrognosisPyroptosis

Identifiers

PMID37071294
OpenAlexW4366235949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.